Get the Stockscreener App
52.94
2.88%
-1.57
After Hours:
53.01
0.07
+0.13%
Viking Therapeutics Inc Stock (VKTX) Latest News
Viking Therapeutics, Inc. (NASDAQ:VKTX) Short Interest Up 27.9% in November - MarketBeat
Fred Alger Management LLC Sells 78,415 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Financial Counselors Inc. Purchases Shares of 45,981 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Citigroup Inc. Has $8.19 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1.9%What's Next? - MarketBeat
Eventide Asset Management LLC Buys 200,000 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Braidwell LP Purchases 50,072 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum - Benzinga
Is Novo Nordisk Stock a Buy? - The Motley Fool
Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow - Yahoo Finance
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 2%Here's What Happened - MarketBeat
Fmr LLC Has $1.05 Billion Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.6%Time to Sell? - MarketBeat
Victory Capital Management Inc. Has $1.22 Million Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 8.1%Should You Buy? - MarketBeat
HC Wainwright Reaffirms Buy Rating for Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Massachusetts Financial Services Co. MA Has $15.72 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1.2%Here's Why - MarketBeat
Westfield Capital Management Co. LP Raises Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Brokers Offer Predictions for VKTX Q4 Earnings - MarketBeat
Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers - MSN
Crewe Advisors LLC Invests $1.04 Million in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
B. Riley Upgrades Viking Therapeutics (NASDAQ:VKTX) to "Strong-Buy" - MarketBeat
B. Riley Securities Initiates Coverage of Viking Therapeutics (VKTX) with Buy Recommendation - MSN
Viking Therapeutics a new buy at B Riley on lead obesity asset VK2735 - MSN
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 0.9%Here's Why - MarketBeat
Why Is Viking Therapeutics (VKTX) Down 29.5% Since Last Earnings Report? - MSN
Viking Therapeutics (NASDAQ:VKTX) Shares Gap UpHere's What Happened - MarketBeat
VKTX Stock Loses Over $1B in a Month: How to Play the Stock? - Yahoo Finance
Viking Therapeutics (NASDAQ:VKTX) Now Covered by Analysts at B. Riley - MarketBeat
B. Riley Securities initiated coverage on Viking Therapeutics with a new price target - Quantisnow
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Bought by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential? - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Shares Up 0.3%Here's What Happened - MarketBeat
11 Reddit Stocks with Biggest Upside Potential - Insider Monkey
13,334 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by Royce & Associates LP - MarketBeat
NASH Updates: Boston Pharma, Viking Line Up As Serious Competitors - Citeline News & Insights
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - AOL
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.5%Here's What Happened - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Earns Outperform Rating from William Blair - MarketBeat
Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 - The Malaysian Reserve
JW Asset Management LLC Acquires Shares of 45,000 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data - MSN
Is It Too Late to Buy Viking Therapeutics Stock? - MSN
Viking phase 2b study of NASH candidate hits primary endpoint - Seeking Alpha
Viking Therapeutics' NASH Drug Shows 75% Disease Resolution in Phase 2b Trial | VKTX Stock News - StockTitan
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1%Here's Why - MarketBeat
3 Things You Need to Know if You Buy Viking Therapeutics Today - AOL
Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.4%Here's What Happened - MarketBeat
What the Options Market Tells Us About Viking Therapeutics - Benzinga
Viking Therapeutics Insiders Sold US$8.9m Of Shares Suggesting Hesitancy - Simply Wall St
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia) - AOL
LJI Wealth Management LLC Has $1.17 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. - AOL
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):